2024-10-082024-10-082009-09-012149-9322https://hdl.handle.net/11452/46012Objective: To analyze a data of Rh D alloimmunized pregnancies and perinatal outcomes due to fetal anemia and managed with intrauterine transfusions.Material and methods: Between 1994 to 2005 years, 119 inrauterine transfusions performed for 31 pregnant Rh alloimmunized women. Files data retrospectively in a department of obstetrics and gynecology were analyzed.Results: Totally 31 RhD immunized pregnant women with complicated fetal anemia were made 119 intrauterine transfusions. 13 fetuses were hydropic. While in 9/13(69,2%) of these hydropic fetuses the condition resolved, it persisted in 4/13(30,8%). The fetal survival was 16/18(88,9%) for nonhydropic, 9/9(100%) for the resolving hydropic, and 2/4(50%) for the persistently hydropic fetuses.Conclusion: Fetal anemia due to RhD alloimmunization can manage with intrauterine transfusions until the end of the 35th week of gestation with a good perinatal outcome.eninfo:eu-repo/semantics/closedAccessFetal anemiaIntrauterine transfusionRhd alloimmunizationScience & technologyLife sciences & biomedicineObstetrics & gynecologyArticle00042249680000317818463